IVA
Price
$2.49
Change
+$0.07 (+2.89%)
Updated
Jan 31, 10:54 AM (EDT)
Capitalization
119.22M
54 days until earnings call
LTRN
Price
$4.86
Change
+$0.05 (+1.04%)
Updated
Jan 31, 11:12 AM (EDT)
Capitalization
49.07M
34 days until earnings call
Ad is loading...

IVA vs LTRN

Header iconIVA vs LTRN Comparison
Open Charts IVA vs LTRNBanner chart's image
Inventiva SA
Price$2.49
Change+$0.07 (+2.89%)
Volume$125
Capitalization119.22M
Lantern Pharma
Price$4.86
Change+$0.05 (+1.04%)
Volume$100
Capitalization49.07M
IVA vs LTRN Comparison Chart
Loading...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVA vs. LTRN commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVA is a Buy and LTRN is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (IVA: $2.42 vs. LTRN: $4.81)
Brand notoriety: IVA and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVA: 257% vs. LTRN: 100%
Market capitalization -- IVA: $119.22M vs. LTRN: $49.07M
IVA [@Biotechnology] is valued at $119.22M. LTRN’s [@Biotechnology] market capitalization is $49.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVA’s FA Score shows that 0 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • IVA’s FA Score: 0 green, 5 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, LTRN is a better buy in the long-term than IVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVA’s TA Score shows that 4 TA indicator(s) are bullish while LTRN’s TA Score has 5 bullish TA indicator(s).

  • IVA’s TA Score: 4 bullish, 5 bearish.
  • LTRN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than IVA.

Price Growth

IVA (@Biotechnology) experienced а -3.97% price change this week, while LTRN (@Biotechnology) price change was +15.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.09%. For the same industry, the average monthly price growth was +1.54%, and the average quarterly price growth was +5.25%.

Reported Earning Dates

IVA is expected to report earnings on Mar 26, 2025.

LTRN is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-1.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVA($119M) has a higher market cap than LTRN($49.1M). LTRN YTD gains are higher at: 50.784 vs. IVA (13.084).
IVALTRNIVA / LTRN
Capitalization119M49.1M242%
EBITDAN/A-21.18M-
Gain YTD13.08450.78426%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A28.1M-
Total DebtN/A291K-
TECHNICAL ANALYSIS
Technical Analysis
IVALTRN
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 25 days ago
73%
Bullish Trend 26 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
IVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AXS92.782.78
+3.09%
Axis Capital Holders Limited
EW73.222.09
+2.94%
Edwards Lifesciences Corp
FBIO1.780.04
+2.30%
Fortress Biotech
TRVI3.900.04
+1.04%
Trevi Therapeutics
CSTM9.89-0.11
-1.10%
Constellium SE

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+5.71%
AXON - LTRN
36%
Loosely correlated
+2.10%
GLYC - LTRN
34%
Loosely correlated
+13.86%
ORMP - LTRN
31%
Poorly correlated
-2.22%
NAUT - LTRN
30%
Poorly correlated
+0.57%
SAGE - LTRN
30%
Poorly correlated
+0.27%
More